Carlyle Group Inc.
Institutional investor · Portfolio as of Q2 2022
Top Holdings9 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
ATOTECH LTD | 153.7M | $3B | 51.3% | — | — | 6 qtrssince 2021-Q1 | Unchanged 0 |
ZOOMINFO TECHNOLOGIES INC | 41.7M | $1.4B | 23.9% | $50.72 | -32.59% | 9 qtrssince 2020-Q2 | Decreased 0 |
QUIDELORTHO CORP | 12.5M | $1.2B | 20.9% | $100.03 | 0.00% | 1 qtr | New 100 |
VITRU LTD | 6.2M | $109.2M | 1.9% | — | — | 8 qtrssince 2020-Q3 | Unchanged 0 |
1LIFE HEALTHCARE INC COM | 13.6M | $106.7M | 1.8% | — | — | 10 qtrssince 2020-Q1 | Unchanged 0 |
SEACOR MARINE HLDGS INC | 1.2M | $6.9M | 0.1% | $11.06 | -46.67% | 15 qtrssince 2018-Q4 | Increased 37 |
SMART SH GLOBAL LTD | 4.8M | $5.3M | 0.1% | $1.12 | 0.00% | 1 qtr | New 40 |
SIRIUSPOINT LTD | 129,408 | $701,000 | 0.0% | $10.29 | -47.81% | 6 qtrssince 2021-Q1 | Unchanged 0 |
| 314,400 | $465,000 | 0.0% | — | — | 1 qtr | New 36 |
Carlyle Group Inc. manages $5.8B across 9 positions as of Q2 2022. Top holdings: ATC (51.3%), GTM (23.9%), QDEL (20.9%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.
Added 3 new positions, exited 1, increased 1, trimmed 1. Top move: QDEL (NEW, conviction 100). Portfolio: $5.8B across 9 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer